- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 219-233 of
645 results
1526 Exhibit: Valeant Pharmaceuticals International, Inc, Investor Conference Call...
Document
IPR2017-00190, No. 1526-175 Exhibit - Valeant Pharmaceuticals International, Inc, Investor Conference Call Presentation, October 26, 2015 (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
1519 Exhibit: Label for Lamisil¿¿ terbinafine DermGel¿¿¿, 1% Gel, Jock Itch Product 6...
Document
IPR2017-00190, No. 1519-168 Exhibit - Label for Lamisil¿¿ terbinafine DermGel¿¿¿, 1% Gel, Jock Itch Product 6g Tube Novartis Consumer Health, Inc, NDA 21 958 (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
2089 Exhibit: Kaken Exhibit 2089
Document
IPR2017-00190, No. 2089-135 Exhibit - Kaken Exhibit 2089 (P.T.A.B. Aug. 1, 2017)
|
|
Cite Document
2034 Exhibit: Kaken Exhibit 2034
Document
IPR2017-00190, No. 2034-81 Exhibit - Kaken Exhibit 2034 (P.T.A.B. Aug. 1, 2017)
|
|
Cite Document
2045 Exhibit: Kaken Exhibit 2045
Document
IPR2017-00190, No. 2045-92 Exhibit - Kaken Exhibit 2045 (P.T.A.B. Aug. 1, 2017)
|
|
Cite Document
1566 Exhibit: 100 Best Selling, Most Prescribed Branded Drugs through March
Document
IPR2017-00190, No. 1566-215 Exhibit - 100 Best Selling, Most Prescribed Branded Drugs through March (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
2037 Exhibit: Kaken Exhibit 2037
Document
IPR2017-00190, No. 2037-84 Exhibit - Kaken Exhibit 2037 (P.T.A.B. Aug. 1, 2017)
|
|
Cite Document
2085 Exhibit: Kaken Exhibit 2085
Document
IPR2017-00190, No. 2085-131 Exhibit - Kaken Exhibit 2085 (P.T.A.B. Aug. 1, 2017)
|
|
Cite Document
1036 Exhibit: Buck, DS et al, The Journal of Family Practice, 386 601 605 1994
Document
IPR2017-00190, No. 1036-36 Exhibit - Buck, DS et al, The Journal of Family Practice, 386 601 605 1994 (P.T.A.B. Nov. 2, 2016)
|
|
Cite Document
1514 Exhibit: Pharmacokinetics of antimycotics with emphasis on local treatment
Document
IPR2017-00190, No. 1514-163 Exhibit - Pharmacokinetics of antimycotics with emphasis on local treatment (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
1521 Exhibit: Final Printed Labeling for Center for Drug Evaluation and Research A...
Document
IPR2017-00190, No. 1521-170 Exhibit - Final Printed Labeling for Center for Drug Evaluation and Research Application No 21 022, Penlac¿¿¿ Nail Lacquer Ciclopirox Topical Solution, 8% (P.T.A.B...
|
|
Cite Document
2048 Exhibit: Kaken Exhibit 2048
Document
IPR2017-00190, No. 2048-95 Exhibit - Kaken Exhibit 2048 (P.T.A.B. Aug. 1, 2017)
|
|
Cite Document
1637 Exhibit: Prescription drug expenditures in 2000 The upward trend continues
Document
IPR2017-00190, No. 1637-286 Exhibit - Prescription drug expenditures in 2000 The upward trend continues (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
1612 Exhibit: Valeant Pharmaceuticals International, Inc First Quarter 2015 Financ...
Document
IPR2017-00190, No. 1612-261 Exhibit - Valeant Pharmaceuticals International, Inc First Quarter 2015 Financial Results Conference Call Presentation (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
1573 Exhibit: Valeant Pharmaceuticals International, Inc 1Q 2017 Financial Results...
Document
IPR2017-00190, No. 1573-222 Exhibit - Valeant Pharmaceuticals International, Inc 1Q 2017 Financial Results Conference Call Presentation (P.T.A.B. Nov. 1, 2017)
|
|
Cite Document
